SOURCE: Therapeutic Solutions International, Inc.

Therapeutic Solutions International, Inc.

July 27, 2011 09:00 ET

James P. Boyd, D.D.S. to Present at Annual Meeting of the Academy of General Dentistry

SAN DIEGO, CA--(Marketwire - Jul 27, 2011) - Therapeutic Solutions International, Inc. (OTCQB: TSOI) (PINKSHEETS: TSOI), the only manufacturer of the chairside NTI Tension Suppression System that has helped countless patients prevent debilitating migraine and tension headache pain, announced today that James P. Boyd, D.D.S., Director of Research and Product Development at Therapeutic Solutions International ("TSI") will present at this year's Academy of General Dentistry ("AGD") Annual Meeting to be held July 28-31 in San Diego, California.

The Academy of General Dentistry (AGD) is a professional association of more than 37,000 general dentists dedicated to staying up to date in the profession through continuing education. The annual "AGD" conference brings together dental professionals to share information and to discuss the enabling technologies that are driving today's dental profession.

Dr. Boyd's presentation titled "Migraine Pain and Trigeminally Mediated Disorders" will focus on the Company's NTI Tension Suppression System ("NTI"). Dr. Boyd is the inventor of the NTI and is credited with establishing an entire new market of drug-free migraine prevention.

"The Academy of General Dentistry is the largest and most prestigious of all the academic societies in the dental industry," said Dr. Boyd. "The AGD represents the mainstream of dentistry in the United States. There is no better organization to help incorporate the basic knowledge and insight of migraine into everyday dentistry."

About Therapeutic Solutions International, Inc.

Therapeutic Solutions International, Inc. is a company that has developed, is producing and currently marketing, the FDA Approved NTI Tension Suppression System for the prevention of medically diagnosed migraine pain. The NTI dental device is the most cost effective, non-drug method of migraine prevention on the market today. TSI currently has strong International Patent Protection in those countries we are marketing our products into. TSI has several important websites to disseminate information and market their products. Our patient education site located at www.headacheprevention.com, and our corporate website for TSI is www.therapeuticsolutionsint.com.

Safe Harbor Statement
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to adverse economic conditions, intense competition, lack of meaningful research results, entry of new competitors and products, adverse federal, state and local government regulation, inadequate capital, termination of contracts or agreements, technological obsolescence of our products, technical problems with our research and products, price increases for supplies and components, inability to carry out research, development and commercialization plans, loss or retirement of key executives and research scientists and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Readers are advised to review our filings with the Securities and Exchange Commission that can be accessed over the Internet at the SEC's website located at http://www.sec.gov.

Contact Information

  • For more information please contact:

    Jens Dalsgaard
    President
    Constellation Asset Advisors, Inc
    (415) 524-8500
    info@constellationaa.com